Back
Amplify Weight Loss Drug & Treatment ETF Stock Price Chart
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
1
THNR
Amplify Weight Loss Drug & Treatment ETF
Last Price:
$21.50
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and THNR is experiencing selling pressure, which indicates risk of future bearish movement.
Amplify Weight Loss Drug & Treatment ETF Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.18 | Sell |
| 20-day SMA: | 22.57 | Sell |
| 50-day SMA: | 22.82 | Sell |
| 200-day SMA: | 24.9 | Sell |
| 8-day EMA: | 22.06 | Sell |
| 20-day EMA: | 22.43 | Sell |
| 50-day EMA: | 22.82 | Sell |
| 200-day EMA: | 24.72 | Sell |
Amplify Weight Loss Drug & Treatment ETF Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 31.5 | Sell |
| Chaikin Money Flow: | -217 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.14 - 23.36) | Sell |
| Bollinger Bands (100): | (22.42 - 24) | Sell |
Amplify Weight Loss Drug & Treatment ETF Technical Analysis
| Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amplify Weight Loss Drug & Treatment ETF Stock
Is Amplify Weight Loss Drug & Treatment ETF Stock a Buy?
-
Amplify Weight Loss Drug & Treatment ETF share price is 21.55 while THNR 8-day simple moving average is 22.18, which is a Sell signal.
-
The stock price of THNR is 21.55 while Amplify Weight Loss Drug & Treatment ETF 20-day SMA is 22.57, which makes it a Sell.
-
Amplify Weight Loss Drug & Treatment ETF 50-day simple moving average is 22.82 while THNR share price is 21.55, making it a Sell technically.
-
THNR stock price is 21.55 and Amplify Weight Loss Drug & Treatment ETF 200-day simple moving average is 24.90, creating a Sell signal.
THNR Technical Analysis vs Fundamental Analysis
Sell
1
Amplify Weight Loss Drug & Treatment ETF (THNR)
is a Sell
Is Amplify Weight Loss Drug & Treatment ETF a Buy or a Sell?
-
Amplify Weight Loss Drug & Treatment ETF stock is rated a SellThe current Amplify Weight Loss Drug & Treatment ETF [THNR] share price is $21.55. The Score for THNR is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
Amplify Weight Loss Drug & Treatment ETF Stock Info
Market Cap:
0
Price in USD:
21.55
Share Volume:
217
Amplify Weight Loss Drug & Treatment ETF 52-Week Range
52-Week High:
28.19
52-Week Low:
21.55
Sell
1
Amplify Weight Loss Drug & Treatment ETF (THNR)
is a Sell
Amplify Weight Loss Drug & Treatment ETF Share Price Forecast
-
What is the Amplify Weight Loss Drug & Treatment ETF stock price today?The Amplify Weight Loss Drug & Treatment ETF stock price is 21.55 USD today.
-
Will THNR stock go up or go down?Amplify Weight Loss Drug & Treatment ETF> share price is forecast to RISE/FALL based on technical indicators
-
Is Amplify Weight Loss Drug & Treatment ETF overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amplify Weight Loss Drug & Treatment ETF is overvalued.
Is Amplify Weight Loss Drug & Treatment ETF Stock a Buy?
-
Amplify Weight Loss Drug & Treatment ETF share price is 21.55 while THNR 8-day exponential moving average is 22.06, which is a Sell signal.
-
The stock price of THNR is 21.55 while Amplify Weight Loss Drug & Treatment ETF 20-day EMA is 22.43, which makes it a Sell.
-
Amplify Weight Loss Drug & Treatment ETF 50-day exponential moving average is 22.82 while THNR share price is 21.55, making it a Sell technically.
-
THNR stock price is 21.55 and Amplify Weight Loss Drug & Treatment ETF 200-day simple moving average is 24.72, creating a Sell signal.
Technical Analysis of Amplify Weight Loss Drug & Treatment ETF
Should I short Amplify Weight Loss Drug & Treatment ETF stock?
-
THNR Moving Average Covergence Divergence (MACD) indicator is -0.31, suggesting Amplify Weight Loss Drug & Treatment ETF is a Sell
-
Amplify Weight Loss Drug & Treatment ETF Relative Strength Index (RSI) is 31.5, which suggest Amplify Weight Loss Drug & Treatment ETF is oversold
-
The Bollinger Bands (25) for Amplify Weight Loss Drug & Treatment ETF is (22.14 - 23.36), which suggest Amplify Weight Loss Drug & Treatment ETF is a Sell
-
The Bollinger Bands (100) for Amplify Weight Loss Drug & Treatment ETF is (22.42 - 24), which suggest Amplify Weight Loss Drug & Treatment ETF is a Sell
* Amplify Weight Loss Drug & Treatment ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.